Clinical Trial Update: TF2- Small Cell Lung Cancer Radio Immunotherapy [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial TF2 radioimmunotherapy for small cell lung cancer and non-small cell lung cancer has completed Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• TF2 (BI-1060469)

Snippet

Sponsor: Centre René Gauducheau | Conditions: Small Cell Lung Cancer, CEA-expressing Non Small Cell Lung Carcinoma (NSCLC) | Phase 1, Phase 2 | Status: COMPLETED